Uncategorized - Dittmar & Indrenius

reference

Biosimilars

We regularly advise clients in matters, which regard pricing and administrative issues relating to competing biosimilars entering the

reference

We have assisted several multinational pharmaceutical companies in their negotiations on Risk Sharing Agreements with the Pharmaceutical Pricing

reference

We represented a multinational technology group in connection with tax audit concerning their post-acquisition IP transaction and business

reference

We assisted a major Finnish private equity firm in the planning and structuring of their new private equity

reference

We assisted a major Finnish private equity firm with a tax adjustment claim related to interest deductibility limitation

reference

We assisted a major Finnish mobility company in connection with evaluating the tax implications of their new technology-based

reference

We represented a Finnish consumer goods manufacturer before the Supreme Administrative Court in a tax dispute related to

reference

We represented a global consumer goods manufacturer before the Supreme Administrative Court in a transfer pricing dispute related

reference

We assisted a Finnish listed company with respect to the tax treatment of employment benefits. The matter related

reference

We assisted a global technology group in obtaining an advance ruling from the Central Tax Board relating to